Cargando…

Comparison of the Effects of Sugammadex, Neostigmine, and Pyridostigmine on Postoperative Nausea and Vomiting: A Propensity Matched Study of Five Hospitals

Thus far, few studies have compared the effects of sugammadex and cholinesterase inhibitors on postoperative nausea and vomiting (PONV), and the results have been controversial. Here, we compared the effects of sugammadex, neostigmine, and pyridostigmine on PONV by means of a five hospital analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jong Ho, Lim, Man-Sup, Choi, Jun Woo, Kim, Haewon, Kwon, Young-Suk, Lee, Jae Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693429/
https://www.ncbi.nlm.nih.gov/pubmed/33126598
http://dx.doi.org/10.3390/jcm9113477
_version_ 1783614742164668416
author Kim, Jong Ho
Lim, Man-Sup
Choi, Jun Woo
Kim, Haewon
Kwon, Young-Suk
Lee, Jae Jun
author_facet Kim, Jong Ho
Lim, Man-Sup
Choi, Jun Woo
Kim, Haewon
Kwon, Young-Suk
Lee, Jae Jun
author_sort Kim, Jong Ho
collection PubMed
description Thus far, few studies have compared the effects of sugammadex and cholinesterase inhibitors on postoperative nausea and vomiting (PONV), and the results have been controversial. Here, we compared the effects of sugammadex, neostigmine, and pyridostigmine on PONV by means of a five hospital analysis with propensity score matching. We analyzed adults aged ≥ 18 years who underwent general anesthesia between January 2014 and December 2019. Following propensity score matching, 7793 patients were included in each of the neostigmine and sugammadex matched patient groups (absolute standardized difference (ASD), 0.01–0.07), and 10,197 patients were included in each of the pyridostigmine and sugammadex matched patient groups (ASD, 0.01–0.02), while 19,377 patients were included in each of the pyridostigmine and neostigmine matched patient groups. (ASD, 0.01–0.19). The odds of PONV were low in the sugammadex group (odds ratio, 0.65; 95% confidence interval, 0.59–0.72; p < 0.0001) and pyridostigmine group (odds ratio, 0.22; 95% confidence interval, 0.20–0.24; p < 0.0001) compared to the neostigmine group, while there was no difference between sugammadex and pyridostigmine (odds ratio, 0.95; 95% confidence interval, 0.86–1.04; p = 0.281). Therefore, sugammadex and pyridostigmine may lower the incidence of PONV compared to neostigmine in patients undergoing general anesthesia.
format Online
Article
Text
id pubmed-7693429
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76934292020-11-28 Comparison of the Effects of Sugammadex, Neostigmine, and Pyridostigmine on Postoperative Nausea and Vomiting: A Propensity Matched Study of Five Hospitals Kim, Jong Ho Lim, Man-Sup Choi, Jun Woo Kim, Haewon Kwon, Young-Suk Lee, Jae Jun J Clin Med Article Thus far, few studies have compared the effects of sugammadex and cholinesterase inhibitors on postoperative nausea and vomiting (PONV), and the results have been controversial. Here, we compared the effects of sugammadex, neostigmine, and pyridostigmine on PONV by means of a five hospital analysis with propensity score matching. We analyzed adults aged ≥ 18 years who underwent general anesthesia between January 2014 and December 2019. Following propensity score matching, 7793 patients were included in each of the neostigmine and sugammadex matched patient groups (absolute standardized difference (ASD), 0.01–0.07), and 10,197 patients were included in each of the pyridostigmine and sugammadex matched patient groups (ASD, 0.01–0.02), while 19,377 patients were included in each of the pyridostigmine and neostigmine matched patient groups. (ASD, 0.01–0.19). The odds of PONV were low in the sugammadex group (odds ratio, 0.65; 95% confidence interval, 0.59–0.72; p < 0.0001) and pyridostigmine group (odds ratio, 0.22; 95% confidence interval, 0.20–0.24; p < 0.0001) compared to the neostigmine group, while there was no difference between sugammadex and pyridostigmine (odds ratio, 0.95; 95% confidence interval, 0.86–1.04; p = 0.281). Therefore, sugammadex and pyridostigmine may lower the incidence of PONV compared to neostigmine in patients undergoing general anesthesia. MDPI 2020-10-28 /pmc/articles/PMC7693429/ /pubmed/33126598 http://dx.doi.org/10.3390/jcm9113477 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Jong Ho
Lim, Man-Sup
Choi, Jun Woo
Kim, Haewon
Kwon, Young-Suk
Lee, Jae Jun
Comparison of the Effects of Sugammadex, Neostigmine, and Pyridostigmine on Postoperative Nausea and Vomiting: A Propensity Matched Study of Five Hospitals
title Comparison of the Effects of Sugammadex, Neostigmine, and Pyridostigmine on Postoperative Nausea and Vomiting: A Propensity Matched Study of Five Hospitals
title_full Comparison of the Effects of Sugammadex, Neostigmine, and Pyridostigmine on Postoperative Nausea and Vomiting: A Propensity Matched Study of Five Hospitals
title_fullStr Comparison of the Effects of Sugammadex, Neostigmine, and Pyridostigmine on Postoperative Nausea and Vomiting: A Propensity Matched Study of Five Hospitals
title_full_unstemmed Comparison of the Effects of Sugammadex, Neostigmine, and Pyridostigmine on Postoperative Nausea and Vomiting: A Propensity Matched Study of Five Hospitals
title_short Comparison of the Effects of Sugammadex, Neostigmine, and Pyridostigmine on Postoperative Nausea and Vomiting: A Propensity Matched Study of Five Hospitals
title_sort comparison of the effects of sugammadex, neostigmine, and pyridostigmine on postoperative nausea and vomiting: a propensity matched study of five hospitals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693429/
https://www.ncbi.nlm.nih.gov/pubmed/33126598
http://dx.doi.org/10.3390/jcm9113477
work_keys_str_mv AT kimjongho comparisonoftheeffectsofsugammadexneostigmineandpyridostigmineonpostoperativenauseaandvomitingapropensitymatchedstudyoffivehospitals
AT limmansup comparisonoftheeffectsofsugammadexneostigmineandpyridostigmineonpostoperativenauseaandvomitingapropensitymatchedstudyoffivehospitals
AT choijunwoo comparisonoftheeffectsofsugammadexneostigmineandpyridostigmineonpostoperativenauseaandvomitingapropensitymatchedstudyoffivehospitals
AT kimhaewon comparisonoftheeffectsofsugammadexneostigmineandpyridostigmineonpostoperativenauseaandvomitingapropensitymatchedstudyoffivehospitals
AT kwonyoungsuk comparisonoftheeffectsofsugammadexneostigmineandpyridostigmineonpostoperativenauseaandvomitingapropensitymatchedstudyoffivehospitals
AT leejaejun comparisonoftheeffectsofsugammadexneostigmineandpyridostigmineonpostoperativenauseaandvomitingapropensitymatchedstudyoffivehospitals